Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 3

Status

Completed 5Unknown 1Terminated 1

Sponsor Class

OTHER 3INDUSTRY 2NETWORK 1INDIV 1

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 7Breast 2Head & Neck 1

Conditions

Colorectal Neoplasms 3Stomach Neoplasms 1Rectal Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Interventional × Uracil × Gastrointestinal × Clear all
NCT00207831 2020-03-25

UFT RT Phase 3

Institut Cancerologie de l'Ouest

Phase 3 Terminated
219 enrolled
Gastrointestinal

Rectal Neoplasms

NCT01225744 2014-06-11

eSCOUT

The Christie NHS Foundation Trust

Phase 2 Completed
47 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00152230 2011-07-07

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)

Taiho Pharmaceutical Co., Ltd.

Phase 3 Completed
900 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00152243 2011-07-07

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)

Taiho Pharmaceutical Co., Ltd.

Phase 3 Completed
500 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00378716 2010-01-11

Combination Chemotherapy in Treating Patients With Resected Colon Cancer

NSABP Foundation Inc

Phase 3 Completed
1,608 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00464919 2009-07-07

Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)

National Taiwan University Hospital

Phase 2 Completed
50 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00037089 2005-06-24

A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer

Edelman, Martin, M.D.

Phase 2 Unknown
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡